top of page

A New Path Forward

Precise treatment for complex depression

SPRAVATO® (esketamine) at Mercury Mental Health

SPRAVATO® is an FDA-approved nasal spray for adults with treatment-resistant depression. It is often covered by insurance (with prior authorization). 
How is SPRAVATO® different from ketamine?
Ketamine contains two forms of molecules (S and R). SPRAVATO® is esketamine, which contains the S form. Esketamine can help people who have not responded well to standard antidepressants.

image.png

This treatment may be a good fit for:

  • Adults who have not experienced sufficient improvement after at least two trials of different antidepressants.

  • Those who want to avoid the typical side effects of standard antidepressants.

  • Adults who struggle with treatment-resistant depression. SPRAVATO® (esketamine) works differently than standard antidepressants and may help some people within hours to days.

Please note: Eligibility will be determined during your initial appointment.

How treatment is scheduled

  • Month One: 2×/week for 4 weeks

  • Month Two: 1×/week for 4 weeks

  • Maintenance: weekly or every 2 weeks

What to expect at your Spravato Ketamine visit

  • Brief check-in and vitals → self-administer SPRAVATO® under supervision → quiet recovery with monitoring (about 2 hours total).

  • Please plan to arrange for a ride home.

Common effects

Dissociation (“spaced-out” feeling), dizziness, sleepiness, nausea, temporary blood pressure increase, headache, bad taste. We monitor and support you onsite.

How to start

  1. Book the intake with Sam Parmenter for evaluation on our [Book Now] page.

  2. Insurance & PA: We recommend benefit verification and prior authorization before your first treatment. Out-of-pocket payment is also an option and financial assistance may be available.

  3. If approved and appropriate, we’ll schedule your first treatment session.

       

Questions? Please email us at: hello@mercurymentalhealth.com

Book now with Sam Parmenter​

Disclaimer: This page is informational and not medical advice. Final eligibility and scheduling follow clinical evaluation, REMS rules, and payer requirements.

For clinicians & referral partners

We accept referrals for SPRAVATO® only—you keep primary medication management.

  • With a signed ROI, we provide regular updates (start, dose/frequency, attendance, brief response/safety notes).

  • We follow REMS requirements and return patients to you for ongoing care once stable.
    Refer/coordinate: hello@mercurymentalhealth.com | Fax (812) 407-2467

bottom of page